Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting
- PMID: 8046486
Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting
Comment on
-
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.J Nucl Med. 1994 Aug;35(8):1313-8. J Nucl Med. 1994. PMID: 7519259 Clinical Trial.
Similar articles
-
Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?J Clin Oncol. 2002 Mar 15;20(6):1709. doi: 10.1200/JCO.2002.20.6.1709. J Clin Oncol. 2002. PMID: 11896125 No abstract available.
-
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.J Nucl Med. 1994 Aug;35(8):1313-8. J Nucl Med. 1994. PMID: 7519259 Clinical Trial.
-
Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.Princess Takamatsu Symp. 1995;25:253-64. Princess Takamatsu Symp. 1995. PMID: 8875631 Review.
-
[Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].Nihon Igaku Hoshasen Gakkai Zasshi. 1984 Jan 25;44(1):96-8. Nihon Igaku Hoshasen Gakkai Zasshi. 1984. PMID: 6330667 Japanese. No abstract available.
-
131-iodine Lipiodol therapy in hepatocellular carcinoma.Q J Nucl Med Mol Imaging. 2009 Jun;53(3):348-55. Q J Nucl Med Mol Imaging. 2009. PMID: 19521315 Review.
Cited by
-
Patient dosimetry for 131I-lipiodol therapy.Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):554-61. doi: 10.1007/s00259-002-1108-7. Epub 2003 Feb 1. Eur J Nucl Med Mol Imaging. 2003. PMID: 12690415 Clinical Trial.
-
X-ray-computed tomography contrast agents.Chem Rev. 2013 Mar 13;113(3):1641-66. doi: 10.1021/cr200358s. Epub 2012 Dec 5. Chem Rev. 2013. PMID: 23210836 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical